Financial Review: Surgery Partners (NASDAQ:SGRY) & Its Peers

Surgery Partners (NASDAQ: SGRY) is one of 15 publicly-traded companies in the “Hospitals, Clinics & Primary Care Services” industry, but how does it weigh in compared to its competitors? We will compare Surgery Partners to similar businesses based on the strength of its dividends, profitability, risk, institutional ownership, analyst recommendations, valuation and earnings.

Earnings & Valuation

This table compares Surgery Partners and its competitors gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Surgery Partners $1.15 billion $9.45 million -29.02
Surgery Partners Competitors $1.06 billion -$22.56 million 890.47

Surgery Partners has higher revenue and earnings than its competitors. Surgery Partners is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Surgery Partners and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Surgery Partners -0.33% 1.03% 0.20%
Surgery Partners Competitors 3.45% 3.46% 4.28%

Volatility and Risk

Surgery Partners has a beta of 1.88, indicating that its share price is 88% more volatile than the S&P 500. Comparatively, Surgery Partners’ competitors have a beta of 1.44, indicating that their average share price is 44% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and price targets for Surgery Partners and its competitors, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surgery Partners 1 3 4 0 2.38
Surgery Partners Competitors 62 331 514 9 2.51

Surgery Partners currently has a consensus price target of $18.00, indicating a potential upside of 34.83%. As a group, “Hospitals, Clinics & Primary Care Services” companies have a potential upside of 12.12%. Given Surgery Partners’ higher probable upside, equities research analysts plainly believe Surgery Partners is more favorable than its competitors.

Institutional & Insider Ownership

94.2% of Surgery Partners shares are held by institutional investors. Comparatively, 69.0% of shares of all “Hospitals, Clinics & Primary Care Services” companies are held by institutional investors. 7.6% of Surgery Partners shares are held by company insiders. Comparatively, 10.4% of shares of all “Hospitals, Clinics & Primary Care Services” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Surgery Partners competitors beat Surgery Partners on 8 of the 13 factors compared.

Surgery Partners Company Profile

Surgery Partners, Inc. is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services. The Company’s surgical facilities primarily provide non-emergency surgical procedures across a range of specialties, which include gastrointestinal (GI), general surgery, ophthalmology, orthopedics and pain management. The Company’s Ancillary Services segment consists of a diagnostic laboratory, a specialty pharmacy and multi-specialty physician practices. The Company’s physician practices include its owned and operated physician practices pursuant to long-term management service agreements. The Company’s Optical Services segment consists of an optical laboratory, an optical products group purchasing organization.

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply